Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • CLC bio Genomics and miRNA nomenclature

    Dear all,

    we are working on analysis of High Throughput sequencing Data from mIRNA analysis. For that reason, we decided to try it with CLC BIO Genomics Workbench. All the steps were very easy and succesfull, but after a detailed analysis of alignments we found a tricky thing.

    When we analysed some miRNA genes, we found that CLC Bio called "precursor" any sequences that mapped in th region of a "mature" along the reference precursor. We dont understand why ClC Bio performed that nomenclature. We think that it should be mature (sub or super or sub/super or whaterver...) because is mapping in the "mature" region.

    Other circumstance is that CLC BIo neve calls miRNA genes by their respectives names. I mean, if one gene is 292 and it has been defined two mature structures as 292-5p and 292-3p, why sequences that mapped in both are called in a different way? Those sequences that mapped in 292-5p were called "mature" and those sequences that mapped in 292-3p were called "precursor". I think CLC Bio should be call both as "mature" but making differences in the gene name.

    I hope if anybody knows why CLC Bio has this behaviour I will be very gratefull because our experiments try to define differences in miRNA variantions at that level.

    Thank you very much!!

  • #2
    Someone on this list may have an answer for you, but you may want to email CLC biosupport "[email protected]" simultaneously about this question.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Current Approaches to Protein Sequencing
      by seqadmin


      Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
      04-04-2024, 04:25 PM
    • seqadmin
      Strategies for Sequencing Challenging Samples
      by seqadmin


      Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
      03-22-2024, 06:39 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 04-11-2024, 12:08 PM
    0 responses
    23 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 10:19 PM
    0 responses
    24 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 09:21 AM
    0 responses
    21 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-04-2024, 09:00 AM
    0 responses
    52 views
    0 likes
    Last Post seqadmin  
    Working...
    X